Total Payments
$47,406
2024 Payments
$1,878
Companies
15
Transactions
86
Medicare Patients
3,976
Medicare Billing
$472,194
Payment Breakdown by Category
Other$38,947 (82.2%)
Consulting$3,650 (7.7%)
Food & Beverage$2,933 (6.2%)
Travel$1,752 (3.7%)
Gifts$118.80 (0.3%)
Education$5.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $38,898 | 31 | 82.1% |
| Consulting Fee | $3,650 | 3 | 7.7% |
| Food and Beverage | $2,933 | 38 | 6.2% |
| Travel and Lodging | $1,752 | 10 | 3.7% |
| Gift | $118.80 | 2 | 0.3% |
| Long term medical supply or device loan | $49.95 | 1 | 0.1% |
| Education | $5.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $34,956 | 46 | $0 (2022) |
| CeQur Corporation | $3,411 | 4 | $0 (2024) |
| Corcept Therapeutics | $3,342 | 6 | $0 (2018) |
| Lilly USA, LLC | $3,088 | 5 | $0 (2020) |
| Mannkind Corporation | $1,779 | 10 | $0 (2024) |
| Medtronic MiniMed, Inc. | $157.38 | 3 | $0 (2017) |
| Shire North American Group Inc | $129.38 | 2 | $0 (2017) |
| Horizon Therapeutics plc | $125.60 | 1 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $125.00 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $116.84 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,878 | 11 | CeQur Corporation ($1,524) |
| 2023 | $1,953 | 4 | CeQur Corporation ($1,887) |
| 2022 | $1,556 | 5 | Mannkind Corporation ($1,418) |
| 2021 | $6,148 | 6 | SANOFI-AVENTIS U.S. LLC ($6,088) |
| 2020 | $6,345 | 10 | SANOFI-AVENTIS U.S. LLC ($3,132) |
| 2019 | $13,655 | 18 | SANOFI-AVENTIS U.S. LLC ($13,596) |
| 2018 | $15,371 | 24 | SANOFI-AVENTIS U.S. LLC ($12,029) |
| 2017 | $500.51 | 8 | Medtronic MiniMed, Inc. ($157.38) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: DIABETES MEDICINE | ||||||
| 09/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Diabetes Care | ||||||
| 09/04/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.10 | General |
| 08/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Bone Health | ||||||
| 08/23/2024 | CeQur Corporation | CeQur Simplicity (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $149.03 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: DIABETES MEDICINE | ||||||
| 07/22/2024 | Abbott Laboratories | FREESTYLE INSULINX (Device) | Long term medical supply or device loan | In-kind items and services | $49.95 | General |
| Category: Diabetes Care | ||||||
| 06/22/2024 | Mannkind Corporation | AFREZZA (Drug) | Travel and Lodging | Cash or cash equivalent | $64.28 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/02/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $102.60 | General |
| Category: DIABETES MEDICINE | ||||||
| 04/16/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: DIABETES MEDICINE | ||||||
| 08/03/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $47.81 | General |
| Category: Insulin Pump | ||||||
| 05/24/2023 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $99.75 | General |
| Category: Diabetes | ||||||
| 04/11/2023 | CeQur Corporation | CeQur Simplicity (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,787.50 | General |
| Category: Diabetes | ||||||
| 03/21/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Endocrinology | ||||||
| 12/16/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/17/2022 | Mannkind Corporation | AFREZZA (Drug) | Consulting Fee | Cash or cash equivalent | $1,275.00 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/17/2022 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $134.30 | General |
| Category: DIABETES MEDICINE | ||||||
| 04/20/2022 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: DIABETES MEDICINE | ||||||
| 01/28/2022 | Takeda Pharmaceuticals U.S.A., Inc. | NATPARA (PARATHYROID HORMONE) (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $125.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/22/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,937.75 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/22/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $90.62 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/12/2021 | MannKind Corporation | AFREZZA (Drug) | Gift | In-kind items and services | $59.40 | General |
| Category: DIABETES MEDICINE | ||||||
| 04/29/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,292.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/29/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,292.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,055 | 4,809 | $503,877 | $125,418 |
| 2022 | 11 | 1,007 | 4,635 | $483,008 | $122,433 |
| 2021 | 12 | 1,059 | 5,636 | $430,019 | $135,344 |
| 2020 | 13 | 855 | 3,852 | $296,029 | $88,999 |
Total Patients
3,976
Total Services
18,932
Medicare Billing
$472,194
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 37 | 3,480 | $264,480 | $63,284 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 323 | 446 | $138,260 | $38,244 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $26,832 | $6,941 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 108 | $23,760 | $6,466 | 27.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 61 | 61 | $23,241 | $4,877 | 21.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 178 | 230 | $10,810 | $2,154 | 19.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 216 | 310 | $4,030 | $979.74 | 24.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,344 | $948.75 | 28.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 32 | 36 | $4,320 | $941.50 | 21.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 42 | 64 | $4,800 | $583.47 | 12.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 39 | 3,360 | $248,640 | $57,104 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 319 | 430 | $130,290 | $38,918 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 82 | 82 | $33,687 | $10,329 | 30.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 71 | 73 | $27,219 | $5,319 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 89 | $19,135 | $5,286 | 27.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 150 | 218 | $10,028 | $2,087 | 20.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 182 | 277 | $3,324 | $894.93 | 26.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 12 | 12 | $948.00 | $822.48 | 86.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 45 | 65 | $4,745 | $635.47 | 13.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 13 | 14 | $4,242 | $616.96 | 14.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $750.00 | $420.60 | 56.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 47 | 4,320 | $233,280 | $69,717 | 29.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 303 | 415 | $96,434 | $38,119 | 39.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 68 | 68 | $29,167 | $8,197 | 28.1% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 70 | 72 | $25,848 | $5,950 | 23.0% |
About Dr. Raymond Stadiem, MD
Dr. Raymond Stadiem, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1639332182.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raymond Stadiem, MD has received a total of $47,406 in payments from pharmaceutical and medical device companies, with $1,878 received in 2024. These payments were reported across 86 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($38,898).
As a Medicare-enrolled provider, Stadiem has provided services to 3,976 Medicare beneficiaries, totaling 18,932 services with total Medicare billing of $472,194. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Internal Medicine
- Location Charlotte, NC
- Active Since 07/04/2008
- Last Updated 07/15/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1639332182
Products in Payments
- TOUJEO (Drug) $11,522
- SOLIQUA 100/33 (Drug) $9,579
- SOLIQUA 100/33 (Biological) $5,719
- SOLIQUA (Drug) $4,620
- TOUJEO (Biological) $3,515
- CeQur Simplicity (Device) $3,411
- Korlym (Drug) $3,342
- BAQSIMI (Drug) $3,088
- AFREZZA (Drug) $1,779
- Minimed 670G System (Device) $157.38
- NATPARA (Drug) $129.38
- TEPEZZA (Drug) $125.60
- NATPARA (PARATHYROID HORMONE) (Drug) $125.00
- FARXIGA (Drug) $116.84
- FREESTYLE INSULINX (Device) $49.95
- Omnipod (Device) $47.81
- FREESTYLE LIBRE 3 (Device) $20.31
- Dexcom G6 Transmitter (Medical Supply) $17.84
- EVENITY (Biological) $16.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Charlotte
Dr. Charles Upchurch, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $267,946
Endocrinology, Diabetes & Metabolism $267,946
Kanakasabai Narasimhan, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $99,422
Endocrinology, Diabetes & Metabolism $99,422
Adam Spitz, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $92,951
Endocrinology, Diabetes & Metabolism $92,951
Dr. David Brantley, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $32,643
Endocrinology, Diabetes & Metabolism $32,643
Nisha Nathan, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $31,707
Endocrinology, Diabetes & Metabolism $31,707
Dr. Gary Rolband, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $14,844
Endocrinology, Diabetes & Metabolism $14,844